Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity

v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock
Additional Paid in Capital
Accumulated Deficits
Accumulated Other Comprehensive Income (Loss)
Total
Beginning Balance at Dec. 31, 2018 $ 9,098 $ 56,582,800 $ (15,292,128) $ 119,964 $ 41,419,734
Beginning Balance, Shares at Dec. 31, 2018 9,098,110        
Stock compensation expense 313,042 313,042
Revaluation of stock warrant (68,200) (68,200)
Other comprehensive income 343,596 343,598
Net loss for the period (2,382,992) (2,382,992)
Beginning Balance at Mar. 31, 2019 $ 9,098 56,827,642 (17,675,120) 463,560 39,625,180
Beginning Balance, Shares at Mar. 31, 2019 9,098,110        
Beginning Balance at Dec. 31, 2019 $ 9,392 69,560,529 (23,271,687) (482,639) 45,815,595
Beginning Balance, Shares at Dec. 31, 2019 9,391,729        
Stock compensation expense 464,827 464,827
Revaluation of stock warrant (66,200) (66,200)
Other comprehensive income 343,775 343,775
Net loss for the period (2,366,494) (2,366,494)
Beginning Balance at Mar. 31, 2020 $ 9,392 $ 69,959,156 $ (25,638,181) $ (138,864) $ 44,191,503
Beginning Balance, Shares at Mar. 31, 2020 9,391,729